X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

TraceLink Announces New Serialized Product Intelligence Solution

Content Team by Content Team
6th November 2020
in Press Statements
TraceLink Introduces New Agile Issue Management Solution

TraceLink, Inc., the leading digital platform company for the life science supply chain, introduced Serialized Product Intelligence™, a new cloud application that uses serialization data to provide actionable intelligence and drive operational excellence. As more compliance mandates continue to emerge around the world, Serialized Product Intelligence simplifies the complexity of managing data across companies’ serialization operations. Now, companies can proactively monitor serialized operations, identify supply chain issues early, avoid costly delays and maintain timely product delivery to market.

Serialized Product Intelligence is a fully automated, self-service analytics application, built on TraceLink’s new Opus Digital Network Platform™, the only digital network platform designed to support the development of multi-enterprise business applications for the pharmaceutical industry. With Serialized Product Intelligence, companies can proactively aggregate and analyze serialization data to accelerate the resolution of supply chain disruptions and improve on-time delivery of medicines.

“Serialization will create enormous value for the entire supply chain, far beyond meeting regulatory requirements. As the crucial link to delivering actionable intelligence, companies can use serialization as the foundation for the digital transformation of their supply chain,” said Shabbir Dahod, president and CEO, TraceLink. “Current processes for managing serialization operations are unsustainable and riddled with complexities, with data coming from various sources and a growing number of new compliance mandates emerging across the globe. Serialized Product Intelligence eliminates these complexities, providing companies with a single source of the truth to identify and resolve disruptions quickly and keep operations on track to ensure medicines reach patients safely and on time.”

Serialized Product Intelligence provides companies with the first step to leverage data as a foundation for using more advanced technologies to predict and prevent critical business issues from occurring. Companies can build on their serialization investment by unlocking the value of serialization data across their enterprise, gaining from the following benefits:

Gain Proactive Control. Companies can proactively access and analyze serialization data at various levels of granularity to monitor their serialized operations and accelerate resolution of inconsistencies between operations and compliance.

Resolve Disruptions Faster. Resolve disruptions and compliance issues up to 75% faster compared to manual intervention with full visibility into serialized operations, including events involving multiple trading partners and systems and ensure that your products are moving through the supply chain.

Streamline Supply Chain Operations. Reduce manual and costly reporting processes by using a fully automated and robust analytical model, avoiding costly disruptions and increasing the probability that suppliers meet their performance targets and products ship on time.

About TraceLink
TraceLink is the leading platform company for the life science supply chain, bringing hundreds of thousands of pharmaceutical companies and healthcare organizations closer to their patients on its digital supply network. In today’s world of unpredictable supply chain disruptions, TraceLink solutions bring the precision, agility and visibility necessary for high performance digital supply chains to thrive in a constantly evolving environment, enabling companies to ensure every patient gets the medicines they need, when they need them, safely and securely. With headquarters in Massachusetts, TraceLink has six global offices through North America, South America, Europe, and Asia.

Previous Post

Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent

Next Post

Vetter continues its long-term investment strategy to sustain future growth

Related Posts

Avadel Pharmaceuticals Receives
Drug Development

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

9th June 2025
ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Drug Development

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

4th March 2025
Next Post
Vetter continues its long-term investment strategy to sustain future growth

Vetter continues its long-term investment strategy to sustain future growth

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In